Neurofilament-light and contactin-1 association with long-term brain atrophy in natalizumab-treated relapsing-remitting multiple sclerosisZoë YGJ van Lierop, Joep Killestein, Martijn D. Steenwijk et al.|Multiple Sclerosis Journal|2022Cited by 11
Association of volumetric MRI measures and disability in MS patients of the same age: Descriptions from a birth year cohortLodewijk R. J. de Ruiter, Bernard M.J. Uitdehaag, Alyssa A Toorop et al.|Multiple Sclerosis and Related Disorders|2023Cited by 11
Exploring the effects of extended interval dosing of natalizumab and drug concentrations on brain atrophy in multiple sclerosisAlyssa A Toorop, Joep Killestein, Bas Jasperse et al.|Multiple Sclerosis Journal|2024Cited by 5